The import of heterocyclic compounds with oxygen hetero-atom only to China is set to expand steadily from 2024 to 2028, with figures moving from $850.97 million to $982.92 million. In 2023, the value was $825 million, showing a solid growth trajectory. Year-on-year growth is robust, averaging approximately 4% annually from 2024 onward. The compound annual growth rate (CAGR) over the five-year period projected is expected to reflect consistent demand and import increase.

Future trends to watch for include:

Advancements in pharmaceutical and biochemical applications driving demand.
Potential trade regulations affecting import levels.
Technological innovations in compound synthesis impacting import patterns positively.